In this article, we discuss new findings which suggest that type I regulatory T (Tr1) cells can interfere with cancer vaccine efficacy in mice by exerting strong regulatory control over antitumor immune responses.
Keywords: Antitumor immune responses; Tr1 cells; cancer immunotherapy; vaccines.
© 2024 the Australian and New Zealand Society for Immunology, Inc.